TY  - RPRT
TI  - CCT2 defines a highly cisplatin-resistant and poor-prognosis subtype of lung adenocarcinoma.
AU  - Huafang Mao
AU  - Chao Su
AU  - Xiaoliang Han
AU  - Guoxia Wang
PY  - 2026
DO  - 10.3892/ol.2026.15836
UR  - https://pubmed.ncbi.nlm.nih.gov/42719221/
ID  - 42719221
ER  -